CoChat

Selective advantage of epigenetically disrupted cancer cells via phenotypic inertia

Open access
Loukas, Ioannis, Simeoni, Fabrizio, Milan, Marta, Inglese, Paolo, Patel, Harshil, Goldstone, Robert, East, Philip, Strohbuecker, Stephanie, Mitter, Richard, Talsania, Bhavik, Tang, Wenhao, Ratcliffe, Colin D.H., Sahai, Erik, Shahrezaei, Vahid, Scaffidi, Paola · 2023 · Cancer Cell
Cited by 46

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The evolution of established cancers is driven by selection of cells with enhanced fitness.Subclonal mutations in numerous epigenetic regulator genes are common across cancer types, yet their functional impact has been unclear.Here, we show that disruption of the epigenetic regulatory network increases the tolerance of cancer cells to unfavorable environments experienced within growing tumors by promoting the emergence of stress-resistant subpopulations.Disruption of epigenetic control does not promote selection of genetically defined subclones or favor a phenotypic switch in response to environmental changes.Instead, it prevents cells from mounting an efficient stress response via modulation of global transcriptional activity.This ''transcriptional numbness'' lowers the probability of cell death at early stages, increasing the chance of long-term adaptation at the population level.Our findings provide a mechanistic explanation for the widespread selection of subclonal epigenetic-related mutations in cancer and uncover phenotypic inertia as a cellular trait that drives subclone expansion.Disruption of the epigenetic regulatory network enhances cell fitness under environmental stress In physiology, epigenetic mechanisms mediate the cellular response to environmental cues.We therefore asked whether disruption of epigenetic control in cancer cells may affect their interactions with the tumor microenvironment (TME).We selected two cancer types originating from distinct lineages: NSCLC lung (D) Visualization of subclonal mutations affecting epigenetic regulator genes in the TRACERx patient cohort.Genes grouped by functional class.Colors legend as in (A).(E) Ratio of nonsynonymous over synonymous mutations in individual genes in the indicated groups.N = 190, 65, and 10,025 genes, respectively.Red lines denote median values.p values relative to the rest of the genes from one-tailed Student's t test after random sampling.(F) Phylogenetic trees visualizing emerging subclones in two tumors.Mutated epigenetic regulator genes identified in the trunk (gray line, clonal mutations) or in the branches (black lines, subclonal mutations) are indicated.Genes color-coded as in (A).See also Figure S1 and Table S1. DECLARATION OF INTERESTSH.P. is currently an employee of Seqera Labs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2022.10.002

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 46

Metadata

Authors
Loukas, I., Simeoni, F., Milan, M., Inglese, P., Patel, H., Goldstone, R., East, P., Strohbuecker, S., Mitter, R., Talsania, B., Tang, W., Ratcliffe, C. D. H., Sahai, E., Shahrezaei, V., & Scaffidi, P.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2023-01
Volume
41
Issue
1
Pages
70-87.e14
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4308108258
Cited by
46
References
30
FWCI
3.26
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective advantage of epigenetically disrupted cancer cells via phenotypic inertia. https://app.cochat.ai/papers/10.1016/j.ccell.2022.10.002
The paper
Loukas, I., Simeoni, F., Milan, M., Inglese, P., Patel, H., Goldstone, R., East, P., Strohbuecker, S., Mitter, R., Talsania, B., Tang, W., Ratcliffe, C. D. H., Sahai, E., Shahrezaei, V., & Scaffidi, P. (2023). Selective advantage of epigenetically disrupted cancer cells via phenotypic inertia. Cancer Cell. https://doi.org/10.1016/j.ccell.2022.10.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.